118 related articles for article (PubMed ID: 7616211)
1. Drug-induced up-regulation of dopamine D2 receptors on cultured cells.
Starr S; Kozell LB; Neve KA
J Neurochem; 1995 Aug; 65(2):569-77. PubMed ID: 7616211
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical regulation of dopamine receptors in transfected 293 cells.
Filtz TM; Artymyshyn RP; Guan W; Molinoff PB
Mol Pharmacol; 1993 Aug; 44(2):371-9. PubMed ID: 8102783
[TBL] [Abstract][Full Text] [Related]
3. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
Zhang LJ; Lachowicz JE; Sibley DR
Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658
[TBL] [Abstract][Full Text] [Related]
4. Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells.
Boundy VA; Pacheco MA; Guan W; Molinoff PB
Mol Pharmacol; 1995 Nov; 48(5):956-64. PubMed ID: 7476927
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
Watts VJ; Neve KA
Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
[TBL] [Abstract][Full Text] [Related]
6. Constitutive oligomerization of human D2 dopamine receptors expressed in Spodoptera frugiperda 9 (Sf9) and in HEK293 cells. Analysis using co-immunoprecipitation and time-resolved fluorescence resonance energy transfer.
Gazi L; López-Giménez JF; Rüdiger MP; Strange PG
Eur J Biochem; 2003 Oct; 270(19):3928-38. PubMed ID: 14511374
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of up-regulation of D2L dopamine receptors by agonists and antagonists in transfected HEK-293 cells.
Filtz TM; Guan W; Artymyshyn RP; Facheco M; Ford C; Molinoff PB
J Pharmacol Exp Ther; 1994 Dec; 271(3):1574-82. PubMed ID: 7996471
[TBL] [Abstract][Full Text] [Related]
8. Regulation and functional characterization of a rat recombinant dopamine D3 receptor.
Cox BA; Rosser MP; Kozlowski MR; Duwe KM; Neve RL; Neve KA
Synapse; 1995 Sep; 21(1):1-9. PubMed ID: 8525456
[TBL] [Abstract][Full Text] [Related]
9. Resistance of the dopamine D2L receptor to desensitization accompanies the up-regulation of receptors on to the surface of Sf9 cells.
Ng GY; Varghese G; Chung HT; Trogadis J; Seeman P; O'Dowd BF; George SR
Endocrinology; 1997 Oct; 138(10):4199-206. PubMed ID: 9322930
[TBL] [Abstract][Full Text] [Related]
10. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.
Lindgren N; Usiello A; Goiny M; Haycock J; Erbs E; Greengard P; Hokfelt T; Borrelli E; Fisone G
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4305-9. PubMed ID: 12651945
[TBL] [Abstract][Full Text] [Related]
11. Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms.
Ventra C; Meucci O; Grimaldi M; Scorziello A; Porcellini A; Schettini G
J Mol Endocrinol; 1995 Jun; 14(3):375-89. PubMed ID: 7669227
[TBL] [Abstract][Full Text] [Related]
12. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
Liu LX; Burgess LH; Gonzalez AM; Sibley DR; Chiodo LA
Synapse; 1999 Feb; 31(2):108-18. PubMed ID: 10024007
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.
Leysen JE; Gommeren W; Mertens J; Luyten WH; Pauwels PJ; Ewert M; Seeburg P
Psychopharmacology (Berl); 1993; 110(1-2):27-36. PubMed ID: 7870895
[TBL] [Abstract][Full Text] [Related]
14. D2L, D2S, and D3 dopamine receptors stably transfected into NG108-15 cells couple to a voltage-dependent potassium current via distinct G protein mechanisms.
Liu LX; Monsma FJ; Sibley DR; Chiodo LA
Synapse; 1996 Oct; 24(2):156-64. PubMed ID: 8890457
[TBL] [Abstract][Full Text] [Related]
15. G protein-mediated mitogen-activated protein kinase activation by two dopamine D2 receptors.
Choi EY; Jeong D; Park KW; Baik JH
Biochem Biophys Res Commun; 1999 Mar; 256(1):33-40. PubMed ID: 10066418
[TBL] [Abstract][Full Text] [Related]
16. Modulation of agonist binding to human dopamine receptor subtypes by L-prolyl-L-leucyl-glycinamide and a peptidomimetic analog.
Verma V; Mann A; Costain W; Pontoriero G; Castellano JM; Skoblenick K; Gupta SK; Pristupa Z; Niznik HB; Johnson RL; Nair VD; Mishra RK
J Pharmacol Exp Ther; 2005 Dec; 315(3):1228-36. PubMed ID: 16126839
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.
Wang Y; Xu R; Sasaoka T; Tonegawa S; Kung MP; Sankoorikal EB
J Neurosci; 2000 Nov; 20(22):8305-14. PubMed ID: 11069937
[TBL] [Abstract][Full Text] [Related]
18. New Dopamine D2 Receptor Agonist, [
Subburaju S; Sromek AW; Seeman P; Neumeyer JL
ACS Chem Neurosci; 2018 Jun; 9(6):1283-1289. PubMed ID: 29641175
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of two isoforms of dopamine D2 receptors in l-dopa-induced abnormal involuntary movements in mice.
Li L; Cheng L; Wang Y
Neuroreport; 2021 May; 32(7):555-561. PubMed ID: 33850083
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D2 receptor stimulation of Na+/H+ exchange assessed by quantification of extracellular acidification.
Neve KA; Kozlowski MR; Rosser MP
J Biol Chem; 1992 Dec; 267(36):25748-53. PubMed ID: 1361188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]